BioSpace News Archive

BioCapital

New Poll Finds Increased Support for Government Action on Drug Prices

With concerns over the costs of prescription drugs taking center stage in American politics during a time when there are shortages of insulin and medical devices like EpiPens, it’s no wonder that the general public is frustrated and is calling on the government to take action of some kind.

March 1, 2019
·
3 min read
·
Alex Keown
Drug Development

ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint

ImmunoGen’s FORWARD I trial was testing the safety and efficacy of mirvetuximab soravtansine compared to chemotherapy in patients with folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer.

March 1, 2019
·
2 min read
·
Alex Keown
Drug Development

Uh-oh! 2 New Studies Emphasize CRISPR Off-Target Edits and Imperfections

CRISPR, the gene editing technique that promises to revolutionize healthcare and medicine, is not perfect. Two new studies, one in mice embryos and the other in rice plants, seem to confirm this.

March 1, 2019
·
3 min read
·
Mark Terry
Business

Abpro and China’s NJCTTQ Ink $4 Billion Development Deal

Abpro, based in Woburn, Mass., inked a deal worth up to $4 billion with China-based Nanjing Chia Tai Tianqing Pharmaceutical Company, known as NJCTTQ, a global pharmaceutical company.

March 1, 2019
·
3 min read
·
Mark Terry
Business

New Tools to the 4 Pillars of Cancer Treatment: Biomarker Testing and Chronic Cancers

Until recently, they were considered to be the three pillars of cancer treatment. Recent years have added a fourth pillar to surgery, radiation and chemotherapy—immuno-oncology.

March 1, 2019
·
5 min read
·
Mark Terry
Drug Development

Researchers Identify New Genes That Could Play Key Role in Development of Alzheimer’s

An analysis of the genetics of nearly 95,000 people across the United States and Europe who have been diagnosed with Alzheimer’s disease has led to the discovery of four new genetic variants in the body that can increase the risk of developing the form of dementia.

March 1, 2019
·
3 min read
·
Alex Keown
Drug Development

Rani Therapeutics’ Biologics Smart-Pill Passes First-in-Human Trial

Most people would prefer to take a pill over an injection, and even an injection over an infusion. But not all drugs can be taken orally. In particular, this applies to most biologics, including insulin.

March 1, 2019
·
3 min read
·
Mark Terry
Policy

Hansa Biopharma Announces European Medicines Agency Accepts Marketing Authorization Application for IDEFIRIX™ (imlifidase)

Hansa Biopharma AB, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced that the European Medicines Agency has accepted the Company’s Marketing Authorization Application for review of IDEFIRIX™.

March 1, 2019
·
3 min read
BioMidwest

New Poll Shows Strong Opposition to Prescription Requirement for Certain OTC Medicines

Michigan Voters Disapprove of Legislation Requiring a Prescription for OTC Cold & Allergy Medicines

March 1, 2019
·
3 min read
Business

Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates

Applied DNA Sciences Inc. announced that LineaRx, Inc. will ship TK7 and ConTRT amplicons to Takis/Evvivax next week as part of the companies’ Joint Development Agreement (“JDA”) entered into in September 2018.

March 1, 2019
·
7 min read